Abstract
B-cell stimulatory factor-1 (BSF-1)1, formerly designated B-cell growth factor, is a T-cell-derived factor required for entry into the S phase of the cell cycle by B cells stimulated with low concentrations of anti-IgM antibodies2–5. BSF-1 acts directly on resting B cells to prepare them to synthesize DNA more promptly on subsequent exposure to competent stimuli6,7 and to strikingly enhance their expression of class II molecules of the major his-tocompatibility complex8,9. Previous studies have shown that murine BSF-1 can be separated physically from interleukin-2 (IL-2) and that the molecule has an apparent relative molecular mass (Mr) of ∼ 15,000 and pI values of 6.4–6.7 and 7.4 (ref. 10). Here, we report the production of a monoclonal antibody to BSF-1, its use in characterizing BSF-1, and functional studies demonstrating that this molecule is distinct from IL-1, IL-2 and IL-3.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Paul, W. E. Molec. Immun. 21, 343 (1984).
Howard, M. et al. J. exp. Med. 155, 914–923 (1982).
Yoshizaki, K. et al. J. Immun. 130, 1241–1246 (1982).
Muraguchi, A., Kasahara, T., Oppenheim, J. & Fauci, A. J. Immun. 129, 2486–2489 (1982).
Maizel, A. L. et al. Proc. natn. Acad. Sci. U.S.A. 80, 5047–5051 (1983).
Rabin, E. M., Ohara, J. & Paul, W. E. Proc. natn. Acad. Sci. U.S.A. 82 (in the press).
Oliver, K., Noelle, R. J., Uhr, J. W., Krammer, P. H. & Vitetta, E. S. Proc. natn. Acad. Sci. U.S.A. 82, 2465–2467 (1985).
Roehm, N. W. et al. J. exp. Med. 160, 679–694 (1984).
Noelle, R., Krammer, P. H., Ohara, J., Uhr, J. W. & Vitetta, E. S. Proc. natn. Acad. Sci. U.S.A. 81, 6149–6153 (1984).
Farrar, J., Howard, M., Fuller-Farrar, J. & Paul, W. E. J. Immun. 131, 1838–1842 (1983).
Kung, J. T. et al. J. Immun. 128, 2049–2056 (1982).
Ortega, G. R., Robb, R. J., Shevach, E. M. & Malek, T. R. J. Immun. 133, 1970–1975 (1984).
O'Farrell, P. H. J. biol. Chem. 250, 4007–4021 (1975).
Towbin, H., Staehelin, T. & Gordon, J. Proc. natn. Acad. Sci. U.S.A. 76, 4350–4354 (1979).
Mizel, S. B. Immun. Rev. 63, 51–72 (1982).
Watson, J. J. exp. Med. 150, 1510–1519 (1979).
Ihle, J. N. et al. J. Immun. 129, 1377–1383 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ohara, J., Paul, W. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 315, 333–336 (1985). https://doi.org/10.1038/315333a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/315333a0
This article is cited by
-
Targeting IL4/IL4R for the treatment of epithelial cancer metastasis
Clinical & Experimental Metastasis (2015)
-
Cytotoxic T lymphocytes generated by short-term in vitro TCR stimulation in the presence of IL-4 are therapeutically effective against B16 melanoma
Journal of Biomedical Science (2003)
-
IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages
Nature Medicine (2002)
-
Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses
Nature Medicine (2001)
-
IL-18–stimulated GADD45β required in cytokine-induced, but not TCR-induced, IFN-γ production
Nature Immunology (2001)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
